Bank of New York Mellon’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $13.5M | Buy |
|
|||||
|
2023
Q1 | $9.24M | Sell |
|
|||||
|
2022
Q4 | $3.87M | Buy |
|
|||||
|
2022
Q3 | $2.5M | Buy |
|
|||||
|
2022
Q2 | $2.81M | Sell |
|
|||||
|
2022
Q1 | $3.95M | Buy |
|
|||||
|
2021
Q4 | $3.13M | Sell |
|
|||||
|
2021
Q3 | $12.6M | Buy |
|
|||||
|
2021
Q2 | $16.9M | Buy |
|
|||||
|
2021
Q1 | $9.48M | Sell |
|
|||||
|
2020
Q4 | $11.9M | Buy |
|
|||||
|
2020
Q3 | $9.12M | Sell |
|
|||||
|
2020
Q2 | $15.3M | Sell |
|
|||||
|
2020
Q1 | $17.1M | Sell |
|
|||||
|
2019
Q4 | $25.3M | Buy |
|
|||||
|
2019
Q3 | $8.49M | Sell |
|
|||||
|
2019
Q2 | $10.7M | Buy |
|
|||||
|
2019
Q1 | $8.87M | Buy |
|
|||||
|
2018
Q4 | $5.05M | Sell |
|
|||||
|
2018
Q3 | $7.76M | Buy |
|
|||||
|
2018
Q2 | $2.29M | Buy |
|
|||||
|
2018
Q1 | $1.01M | Buy |
|
|||||
|
2017
Q4 | $1.34M | Buy |
|
|||||
|
2017
Q3 | $1.39M | Buy |
|
|||||
|
2017
Q2 | $1.07M | Buy |
|
|||||
|
2017
Q1 | $503K | Buy |
|
|||||
|
2016
Q4 | $411K | Buy |
|
|||||
|
2016
Q3 | $410K | Buy |
|
|||||
|
2016
Q2 | $217K | Buy |
|